161 related articles for article (PubMed ID: 6412442)
1. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
Springall DR; Gu J; Cocchia D; Michetti F; Levene A; Levene MM; Marangos PJ; Bloom SR; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):331-43. PubMed ID: 6412442
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application.
Nakajima T; Watanabe S; Sato Y; Kameya T; Shimosato Y; Ishihara K
Cancer; 1982 Sep; 50(5):912-8. PubMed ID: 6807528
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of malignant melanoma.
Hirano T
Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
[TBL] [Abstract][Full Text] [Related]
5. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
[TBL] [Abstract][Full Text] [Related]
6. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
Williams RA; Rode J; Dhillon AP; Jarvis LR; Skinner JM; Jamal O
J Clin Pathol; 1986 Oct; 39(10):1096-8. PubMed ID: 2431005
[TBL] [Abstract][Full Text] [Related]
7. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
[TBL] [Abstract][Full Text] [Related]
8. S100 protein: a marker for human malignant melanomas?
Gaynor R; Herschman HR; Irie R; Jones P; Morton D; Cochran A
Lancet; 1981 Apr; 1(8225):869-71. PubMed ID: 6112296
[TBL] [Abstract][Full Text] [Related]
9. Detection of S-100 protein as an aid to the identification of melanocytic tumors.
Cochran AJ; Wen DR; Herschman HR; Gaynor RB
Int J Cancer; 1982 Sep; 30(3):295-7. PubMed ID: 6752046
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining of neuron-specific enolase as a diagnostic tool for Merkel cell tumors.
Gu J; Polak JM; Van Noorden S; Pearse AG; Marangos PJ; Azzopardi JG
Cancer; 1983 Sep; 52(6):1039-43. PubMed ID: 6349776
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
13. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
Burnier MN; McLean IW; Gamel JW
Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.
Cho KH; Hashimoto K; Taniguchi Y; Pietruk T; Zarbo RJ; An T
Cancer; 1990 Aug; 66(4):765-71. PubMed ID: 2201426
[TBL] [Abstract][Full Text] [Related]
16. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
Dhillon AP; Rode J
Diagn Histopathol; 1982; 5(3):169-74. PubMed ID: 6183082
[TBL] [Abstract][Full Text] [Related]
17. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
Duray PH; Palazzo J; Gown AM; Ohuchi N
Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
[TBL] [Abstract][Full Text] [Related]
18. Detection of S-100 protein in melanocytic and neurogenic cutaneous tumors.
Yambe H; Ishii Y; Tabuchi K; Isobe T; Kikuchi K
Arch Dermatol Res; 1984; 276(3):160-4. PubMed ID: 6383227
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemistry of neurotropic melanoma.
Warner TF; Lloyd RV; Hafez GR; Angevine JM
Cancer; 1984 Jan; 53(2):254-7. PubMed ID: 6360335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
